These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37083736)

  • 1. Highly modular hepatitis B virus-like nanocarriers for therapeutic protein encapsulation and targeted delivery to triple negative breast cancer cells.
    Yur D; Sullivan MO; Chen W
    J Mater Chem B; 2023 May; 11(18):3985-3993. PubMed ID: 37083736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modular Hepatitis B Virus-like Particle Platform for Biosensing and Drug Delivery.
    Hartzell EJ; Lieser RM; Sullivan MO; Chen W
    ACS Nano; 2020 Oct; 14(10):12642-12651. PubMed ID: 32924431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Hepatitis B Virus (HBV) Protein Particles for Therapeutic Delivery.
    Sullivan MO; Chen W
    Methods Mol Biol; 2024; 2720():115-126. PubMed ID: 37775661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GE11-antigen-loaded hepatitis B virus core antigen virus-like particles efficiently bind to TNBC tumor.
    Zhang L; Tang L; Jiang Y; Wang C; Huang L; Ding T; Zhang T; Li H; Xie L
    Front Oncol; 2023; 13():1110751. PubMed ID: 37020877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Epidermal Growth Factor Receptor Ligand Display on Cancer Suicide Enzymes via Unnatural Amino Acid Engineering for Enhanced Intracellular Delivery in Breast Cancer Cells.
    Lieser RM; Chen W; Sullivan MO
    Bioconjug Chem; 2019 Feb; 30(2):432-442. PubMed ID: 30615416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of target-tunable P22 VLP-based delivery nanoplatforms using bacterial superglue.
    Kim H; Choi H; Bae Y; Kang S
    Biotechnol Bioeng; 2019 Nov; 116(11):2843-2851. PubMed ID: 31329283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of targeted therapy therapeutics to sensitize triple-negative breast cancer chemosensitivity utilizing bacteriophage phi29 derived packaging RNA.
    Zhang L; Mu C; Zhang T; Yang D; Wang C; Chen Q; Tang L; Fan L; Liu C; Shen J; Li H
    J Nanobiotechnology; 2021 Jan; 19(1):13. PubMed ID: 33413427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatitis B virus-derived virus-like particle as a drug and DNA delivery carrier.
    Sakai C; Hosokawa K; Watanabe T; Suzuki Y; Nakano T; Ueda K; Fujimuro M
    Biochem Biophys Res Commun; 2021 Dec; 581():103-109. PubMed ID: 34678685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering E2 Bionanoparticles for Targeted Delivery of Chemotherapeutics to Breast Cancer Cells.
    Sullivan MO; Chen W
    Methods Mol Biol; 2024; 2720():177-189. PubMed ID: 37775666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent protein display on Hepatitis B core-like particles in plants through the in vivo use of the SpyTag/SpyCatcher system.
    Peyret H; Ponndorf D; Meshcheriakova Y; Richardson J; Lomonossoff GP
    Sci Rep; 2020 Oct; 10(1):17095. PubMed ID: 33051543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours.
    Suffian IFBM; Al-Jamal KT
    Adv Drug Deliv Rev; 2022 Jan; 180():114030. PubMed ID: 34736988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric virus-like particles (VLPs) designed from shrimp nodavirus (MrNV) capsid protein specifically target EGFR-positive human colorectal cancer cells.
    Grataitong K; Huault S; Chotwiwatthanakun C; Jariyapong P; Thongsum O; Chawiwithaya C; Chakrabandhu K; Hueber AO; Weerachatyanukul W
    Sci Rep; 2021 Aug; 11(1):16579. PubMed ID: 34400669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.
    Burande AS; Viswanadh MK; Jha A; Mehata AK; Shaik A; Agrawal N; Poddar S; Mahto SK; Muthu MS
    AAPS PharmSciTech; 2020 May; 21(5):151. PubMed ID: 32440910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.
    Kim MW; Jeong HY; Kang SJ; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Lee JS; Lee A; Park YS
    Theranostics; 2019; 9(3):837-852. PubMed ID: 30809312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher.
    Yang JI; Kim KH
    Mar Biotechnol (NY); 2022 Dec; 24(6):1066-1072. PubMed ID: 36171522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.